Anzeige
Mehr »
Lynx Broker
Login
Sonntag, 15.09.2019 Börsentäglich über 12.000 News von 610 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 885823 ISIN: US3755581036 Ticker-Symbol: GIS 
Tradegate
13.09.19
19:11 Uhr
60,29 Euro
+0,33
+0,55 %
1-Jahres-Chart
GILEAD SCIENCES INC Chart 1 Jahr
5-Tage-Chart
GILEAD SCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
59,85
60,21
14.09.
59,96
60,12
13.09.

Aktuelle News zur GILEAD SCIENCES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
Börsennews zur GILEAD SCIENCES Aktie und weiteren Hot Stocks erhalten
SaBetter Buy: Celgene vs. Gilead Sciences18
Mi4 Key Questions for Gilead Sciences' New CEO43
MiGilead, Elton John AIDS Foundation launch HIV initiative11
MiGilead Sciences/Pharmstandart signed agreement20
MiXFRA DIVIDEND/INTEREST INFORMATION - 12.09.2019 - 1724FOLGENDE WERTPAPIERE WERDEN AM 11.09.2019 CUM DIVIDENDE/ZINSEN UND AM 12.09.2019 EX DIVIDENDE/ZINSEN GEHANDELT. THE PRE-DIVIDEND/INTEREST DAY OF THE FOLLOWING SHARES WILL BE 11.09.2019. THE EX-DIVIDEND/INTEREST...
► Artikel lesen
DiGilead Sciences, Inc. (GILD) CEO Daniel O'Day presents at Morgan Stanley Global Healthcare Conference (Transcript)15
MoDurect earns $10M milestone from Gilead under SABER license deal18
MoGilead Sciences and the Elton John AIDS Foundation Launch RADIAN Initiative to Address HIV in Eastern Europe and Central Asia (EECA)305-- Initiative to Provide Support to Local Organizations Working to Positively Impact the Lives of People Affected by and at Risk of HIV -- Gilead Sciences, Inc. (Nasdaq: GILD) and the Elton John...
► Artikel lesen
05.09.Is Gilead Stock A Buy Right Now? Here's What Earnings, Chart Show89
29.08.FDA red-flags liver risks for AbbVie, Merck, Gilead hep C drugs49
28.08.UPDATE 1-FDA flags risks from AbbVie, Gilead, Merck hepatitis C drugs to certain patients27
28.08.Galapagos NV: Transparency notification - Gilead holds 22% of Galapagos shares384Mechelen, Belgium; 28 August 2019; 22.01 CEST; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Gilead Sciences, Inc. Pursuant to Belgian...
► Artikel lesen
28.08.FDA flags serious risks with hepatitis C drugs from AbbVie, Gilead and Merck15
27.08.GILEAD SCIENCES INC - 8-K, Current Report18
27.08.Gilead & Galapagos Close Research & Development Agreement24
26.08.Gilead Sciences to Present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 10389Webcast Available Through Gilead Corporate Website Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Daniel O'Day, Gilead's Chairman and Chief Executive Officer, will participate in a fireside...
► Artikel lesen
26.08.3 Big Stock Charts for Monday: Intuit, Gilead Sciences and Nike30
26.08.Gilead, Galapagos finalise £4.1bn research and development deal20
23.08.Gilead and Galapagos consummate R&D partnership15
23.08.Galapagos NV: Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration955Foster City, Calif. and Mechelen, Belgium; 23 August 2019; 22.01 CET; regulated information - Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced the closing...
► Artikel lesen
Seite:  Weiter >>
503 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
20,16,100